Search Results
Aug 24, 2026, 08:00 ET LEQEMBI IQLIK®(lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer's Disease
in the daily living domain, and to increase the benefits that health care provides." Under this Concept (also known as human health care (hhc) Concept), we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global
More news about: Eisai Inc.
Jul 28, 2026, 08:21 ET CORE Biomedicine Signs Exclusive Licensing Agreement with Eisai for Precision Oncology Programs
people in the daily living domain, and to increase the benefits that health care provides." Under this Concept (also known as human health care (hhc) Concept), Eisai aims to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global
More news about: CORE Biomedicine
Jul 14, 2026, 11:15 ET LEQEMBI® Real-World LEADER Study Presented at AAIC® 2026 Finds Over 75% of Early Alzheimer's Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment
in the daily living domain, and to increase the benefits that health care provides." Under this Concept (also known as human health care (hhc) Concept), we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global
More news about: Eisai Inc.
Jul 13, 2026, 17:36 ET FDA Approves LEQEMBI IQLIK® (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer's Disease
in the daily living domain, and to increase the benefits that health care provides." Under this Concept (also known as human health care (hhc) Concept), we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global
More news about: Eisai Inc.
Jul 12, 2026, 11:15 ET LEQEMBI® Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer's Disease Presented at the Alzheimer's Association International Conference® (AAIC®) 2026
people in the daily living domain, and to increase the benefits that health care provides." Under this Concept (also known as human health care (hhc) Concept), we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global
More news about: Eisai Inc.
Jun 22, 2026, 09:00 ET HOUSTON TX HOT CHICKEN TAKES ITS HEAT GLOBAL WITH UK DEBUT
TX Hot Chicken. "No one knows fried chicken better than HHC, and no one knows the UK market better than PizzaExpress. We can't wait to fly the coop and land in the UK, bringing something unexpected and exciting to chicken consumers."HHC has built its U.S. following on the strength of an unapologetically
More news about: Savory Fund
Jun 01, 2026, 07:00 ET Eisai and CaringKind Launch New Initiative to Address Mealtime and Nutrition Needs for People Living with Alzheimer's Disease and Related Dementias
thought to patients and their families and increasing the benefits that health care provides. We call this human health care (hhc).This commitment to hhc is the foundation for our Magnolia programs, initiatives focused on providing patients and their families with support and meeting
More news about: Eisai Inc.
May 20, 2026, 08:08 ET Eisai Deepens Body of Clinical Evidence for LENVIMA (Lenvatinib) Across Established Indications at ASCO 2026
the daily living domain, and to increase the benefits that health care provides." Under this Concept [also known as our human health care (hhc) Concept], we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global
More news about: Eisai Inc.
May 08, 2026, 02:30 ET Update on FDA Priority Review of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection as a Starting Dose for Early Alzheimer's Disease
in the daily living domain, and to increase the benefits that health care provides." Under this Concept (also known as human health care (hhc) Concept), we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global
More news about: Eisai Co., Ltd.
Apr 10, 2026, 07:00 ET New Survey Data Exploring Patient Experiences with Endometrial Cancer Care Presented at 2026 Society of Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer
the daily living domain, and to increase the benefits that health care provides." Under this Concept [also known as our human health care (hhc) Concept], we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global
More news about: Eisai Inc.
Mar 26, 2026, 16:05 ET Eisai and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated by the European Medicines Agency
in the daily living domain, and to increase the benefits that health care provides." Under this Concept (also known as human health care (hhc) Concept), we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global
More news about: Nuvation Bio Inc.; Eisai Co., Ltd
Mar 26, 2026, 09:00 ET HARTFORD HEALTHCARE AND K HEALTH LAUNCH PATIENTGPT A NEW 24/7 AI BRIDGE TO THE CLINICAL CARE TEAM
HHC 24/7 virtual care, or schedule in-person primary-care or specialty appointment. HHC hopes the combination of targeted education and access to telehealth or in-person care will eliminate the
More news about: Hartford HealthCare & K Health
Mar 26, 2026, 08:00 ET EISAI TO BEGIN ENROLLING PHASE 2 STUDY IN PATIENTS WITH NARCOLEPSY
improve patients' symptoms by enhancing orexin receptor activity.About Eisai Inc.Eisai Inc. is a human health care (hhc) company dedicated to improving the lives of people affected by cancer, Alzheimer's disease and other neurodegenerative conditions. Everything we
More news about: Eisai Inc.
Mar 20, 2026, 12:05 ET Results from Real-World, Long-Term Treatment Persistence with LEQEMBI® (lecanemab-irmb) in the United States Presented at AD/PD™ 2026
in the daily living domain, and to increase the benefits that health care provides." Under this Concept (also known as human health care (hhc) Concept), we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global
More news about: Eisai Inc.
Feb 26, 2026, 08:08 ET Eisai and Advocacy Leaders Launch "Kompass," a Digital Destination to Help Patients and Caregivers Navigate the Complexities of Kidney Cancer
the daily living domain, and to increase the benefits that health care provides." Under this Concept [also known as our human health care (hhc) Concept], we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global
More news about: Eisai Inc.
Feb 05, 2026, 06:44 ET Eisai and Henlius Enter into Exclusive Commercial License Agreement for Anti-PD-1 Antibody Serplulimab in Japan
in the daily living domain, and to increase the benefits that health care provides." Under this Concept (also known as human health care (hhc) Concept), we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global
More news about: Henlius
Feb 02, 2026, 15:02 ET Jeffrey A. Flaks recognized as Press Ganey's HX26 Innovator of the Year
intelligence, and advanced analytics — into clinical and operational workflows to meaningfully improve care delivery.A visible example of this work is HHC 24/7, Hartford HealthCare's virtual primary care platform, which gives patients round-the-clock access to both scheduled and on-demand clinical care.
More news about: Hartford HealthCare
Jan 25, 2026, 18:30 ET FDA Accepts LEQEMBI® IQLIKTM (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review
in the daily living domain, and to increase the benefits that health care provides." Under this Concept (also known as human health care (hhc) Concept), we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global
More news about: Eisai Inc.
Dec 22, 2025, 12:47 ET Loonen Sets a New Standard for Bottled Water with Unmatched Purity and Transparency
board includes Robin Berzin, MD (functional medicine), Manasa Mantravadi, MD (pediatrics), Kelly LeVeque, CCN (clinical nutrition), and Alisa Vitti, HHC, AADP (hormonal health and nutrition)."As a pediatrician, I've seen how something as simple as water can be one of the most powerful tools for
More news about: Loonen
Dec 16, 2025, 08:30 ET 5 Hartford HealthCare ambulatory surgery centers recognized nationally with Leapfrog award
includes:HHC Cheshire Surgery Center, second consecutive yearHHC Southwest Connecticut Surgery Center in Wilton, second consecutive yearHHC Hartford Surgery Center, second recognitionHHC Rocky Hill Surgery Center, second recognitionHHC Surgery Center East
More news about: Constitution Surgery Alliance
Dec 15, 2025, 16:02 ET Costs of Care and The Leapfrog Group Honor Hartford HealthCare CEO Jeffrey A. Flaks with Steven Schroeder Award for Outstanding Healthcare Leadership
includes:HHC Cheshire Surgery Center, second consecutive yearHHC Southwest Connecticut Surgery Center in Wilton, second consecutive yearHHC Hartford Surgery Center, second recognitionHHC Rocky Hill Surgery Center, second recognitionHHC Surgery Center East
More news about: Hartford HealthCare
Dec 09, 2025, 08:44 ET Mamba Brand CEO Claims FDA & DEA Lack Funding and Law Enforcement Capacity to Enforce New Hemp Ban
prohibition on products containing more than 0.4 milligrams of total THC per package, effectively banning popular cannabinoids such as delta-8 THC, HHC, high-THCA flower, and several other hemp-derived consumables."It remains unclear if and how federal law enforcement will enforce the new prohibitions…""Both
More news about: The Mamba Brand LLC
Dec 03, 2025, 18:10 ET Eisai Presents New Data on the Continued and Expanding Benefit of LEQEMBI® (lecanemab-irmb) Maintenance Treatment in Early Alzheimer's Disease at the Clinical Trials on Alzheimer's Disease (CTAD) Conference 2025
in the daily living domain, and to increase the benefits that health care provides." Under this Concept (also known as human health care (hhc) Concept), we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global
More news about: Eisai Inc.
Dec 02, 2025, 16:40 ET New Data Presented at the Clinical Trials on Alzheimer's Disease (CTAD) Conference 2025 Confirms Pharmacological Effect of LEQEMBI® (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF
in the daily living domain, and to increase the benefits that health care provides." Under this Concept (also known as human health care (hhc) Concept), we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global
More news about: Eisai Inc.
Nov 25, 2025, 07:30 ET Eisai Completes Rolling Submission to U.S. FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status
in the daily living domain, and to increase the benefits that health care provides." Under this Concept (also known as human health care (hhc) Concept), we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global
More news about: Eisai Inc.